Responses
Regular and young investigator award abstracts
Clinical trials in progress
358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC)
Compose a Response to This Article
Other responses
No responses have been published for this article.
